Pipsa Saharinen
Impact in
Papers in
-
- Angiogenesis and VEGF in Cancer 35
- PI3K/AKT/mTOR signaling in cancer 6
- Oncology 43
- Lymphatic System and Diseases 20
- Cytokine Signaling Pathways and Interactions 18
- Co-authors
- Kari Alitalo (35 shared papers)Olli Silvennoinen (18 shared papers)Lauri Eklund (11 shared papers)Nicholas P.J. Brindle (2 shared papers)Kati Takaluoma (4 shared papers)Tuomas Tammela (5 shared papers)Veli‐Matti Leppänen (6 shared papers)Marko Pesu (1 shared paper)
- Journals
- Journal of Clinical Investigation (6 papers)Molecular and Cellular Biology (5 papers)Blood (5 papers)Nature Communications (2 papers)Circulation Research (2 papers)
- Partner nations
- FinlandUnited StatesSouth Korea
In The Last Decade
Pipsa Saharinen
69 papers receiving 6.4k citations
Pipsa Saharinen's Hit Papers
Peers
Comparison fields: 5 of 123
- Oncology 2.6k
- Genetics 793
- Cancer Research 930
- Immunology and Allergy 364
- Molecular Biology 3.5k
Countries citing papers authored by Pipsa Saharinen
This map shows the geographic impact of Pipsa Saharinen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pipsa Saharinen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pipsa Saharinen more than expected).
Fields of papers citing papers by Pipsa Saharinen
This network shows the impact of papers produced by Pipsa Saharinen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pipsa Saharinen. The network helps show where Pipsa Saharinen may publish in the future.
Co-authors
The 25 scholars most cited alongside Pipsa Saharinen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 489 | |
| 2 | Therapeutic targeting of the angiopoietin–TIE pathway Hit paper breakdown → | 2017 | 428 |
| 3 | 2011 | 393 | |
| 4 | 2006 | 366 | |
| 5 | 2008 | 352 | |
| 6 | 2004 | 319 | |
| 7 | 2000 | 275 | |
| 8 | 2002 | 237 | |
| 9 | 2015 | 213 | |
| 10 | 2002 | 211 | |
| 11 | 2013 | 196 | |
| 12 | 2016 | 189 | |
| 13 | 2016 | 176 | |
| 14 | 2003 | 173 | |
| 15 | 2014 | 171 | |
| 16 | 2015 | 162 | |
| 17 | 2005 | 161 | |
| 18 | 2014 | 151 | |
| 19 | 2016 | 149 | |
| 20 | 2013 | 126 |
About Pipsa Saharinen
Pipsa Saharinen is a scholar working on Molecular Biology, Oncology, Immunology, Cancer Research and Pharmacology, having authored 69 papers that have together received 6.5k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (35 papers), Lymphatic System and Diseases (20 papers), Cytokine Signaling Pathways and Interactions (18 papers), Pharmacological Effects of Natural Compounds (10 papers), Lipid metabolism and disorders (9 papers), Immune Cell Function and Interaction (7 papers), Cell Adhesion Molecules Research (6 papers) and PI3K/AKT/mTOR signaling in cancer (6 papers). The work is most often cited by research in Oncology (2.6k citations), Genetics (793 citations), Cancer Research (930 citations), Immunology and Allergy (364 citations) and Molecular Biology (3.5k citations). Pipsa Saharinen has collaborated with scholars based in Finland, United States and South Korea. Frequent co-authors include Kari Alitalo, Olli Silvennoinen, Lauri Eklund, Nicholas P.J. Brindle, Kati Takaluoma, Tuomas Tammela, Veli‐Matti Leppänen, Marko Pesu, Kunihiro Yamaoka and John J. O’Shea. Their work appears in journals such as Journal of Clinical Investigation, Molecular and Cellular Biology, Blood, Nature Communications and Circulation Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.